Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
Krause
Lothar
L
Department of Ophthalmology, University Medical Center Benjamin Franklin, Freie Universität Berlin, Berlin, Germany.
Turnbull
Julia R
JR
Torun
Necip
N
Pleyer
Uwe
U
Zouboulis
Christos C
CC
Foerster
Michael H
MH
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009901:Optic Nerve Diseases / Q000188:drug therapy / Q000209:etiology; D011994:Recombinant Proteins; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins